TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Diamyd Medical AB
Closing information (x1000 EUR)
| Closing information | 2024/08 (consolidated) | 2023/08 (consolidated) | 2022/08 (consolidated) |
| Turnover |
11
|
46
|
43 |
| Financial expenses |
1,052
|
0
|
24 |
| Earnings before taxes |
-13,396
|
-9,801
|
-9,691 |
| EBITDA |
-11,960
|
-9,789
|
-10,652 |
| Total assets |
19,147
|
17,377
|
22,142 |
| Current assets |
14,039
|
11,889
|
16,196 |
| Current liabilities |
3,531
|
1,676
|
2,000 |
| Equity capital |
12,873
|
14,303
|
20,069 |
| - share capital |
892
|
735
|
730 |
| Employees (average) |
25
|
22
|
0 |
Financial ratios
| Fiscal year | 2024/08 (consolidated) | 2023/08 (consolidated) | 2022/08 (consolidated) |
| Solvency |
67.2%
|
82.3%
|
90.6% |
| Turnover per employee |
0
|
2 | |
| Profit as a percentage of turnover |
-121781.8%
|
-21306.5%
|
-22537.2% |
| Return on assets (ROA) |
-64.5%
|
-56.4%
|
-43.7% |
| Current ratio |
397.6%
|
709.4%
|
809.8% |
| Return on equity (ROE) |
-104.1%
|
-68.5%
|
-48.3% |
| Change turnover |
-37
|
8
|
19 |
| Change turnover % |
-76%
|
20% | |
| Chg. No. of employees |
3
|
22
|
-14 |
| Chg. No. of employees % | 14% |
Total value of public sale
| Fiscal year | 2024/08 (consolidated) | 2023/08 (consolidated) | 2022/08 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.